Furthermore, it is suggested that combinational L-SNA that targets both TNFA and IL17RA simultaneously may mitigate the course of the disease and improve treatment efficiency in severe cases of psoriasis (Table 2) [175]. Here, IL17RA is linked to psoriasis.